ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
HCW Biologics Inc

HCW Biologics Inc (HCWB)

1.50
-0.12
( -7.41% )
Updated: 10:42:59

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
1.50
Bid
1.50
Ask
1.60
Volume
2,669
1.50 Day's Range 1.61
0.91 52 Week Range 2.32
Market Cap
Previous Close
1.62
Open
1.60
Last Trade
2
@
1.56
Last Trade Time
11:02:29
Financial Volume
$ 4,097
VWAP
1.5349
Average Volume (3m)
16,858
Shares Outstanding
35,974,570
Dividend Yield
-
PE Ratio
-3.62
Earnings Per Share (EPS)
-0.41
Revenue
6.72M
Net Profit
-14.9M

About HCW Biologics Inc

HCW Biologics Inc is a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company believes age-related low-grade chronic inflammation is a signi... HCW Biologics Inc is a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company believes age-related low-grade chronic inflammation is a significant contributing factor to several chronic diseases and conditions, such as cancer, cardiovascular disease, diabetes, neurodegenerative diseases, and autoimmune diseases. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
HCW Biologics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker HCWB. The last closing price for HCW Biologics was $1.62. Over the last year, HCW Biologics shares have traded in a share price range of $ 0.91 to $ 2.32.

HCW Biologics currently has 35,974,570 shares outstanding. The market capitalization of HCW Biologics is $53.96 million. HCW Biologics has a price to earnings ratio (PE ratio) of -3.62.

HCWB Latest News

HCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business Highlights

MIRAMAR, Fla., April 01, 2024 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.04-2.59740259741.541.931.5143261.65822053CS
4-0.29-16.20111731841.791.931.5118851.68702555CS
120.3429.31034482761.161.931.1168581.51176997CS
26-0.33-18.03278688521.832.030.91170911.40330304CS
52001.52.320.91151681.61470592CS
156-6-807.57.510.913092244.424954CS
260-6-807.57.510.913092244.424954CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WISAWiSA Technologies Inc
$ 3.775
(115.71%)
70.74M
SXTCChina SXT Pharmaceuticals Inc
$ 2.2707
(94.08%)
20.88M
PALIPalisade Bio Inc
$ 6.51
(56.49%)
21.36M
JAGXJaguar Health Inc
$ 0.1814
(52.69%)
430.19M
PRSOPeraso Inc
$ 1.8801
(48.04%)
44.1M
PACBPacific Biosciences of California Inc
$ 1.585
(-44.09%)
27.73M
NXLNexalin Technologies Inc
$ 1.2299
(-37.88%)
469.09k
KAVLKaival Brands Innovations Group Inc
$ 4.37
(-30.63%)
1.43M
RVYLRYVYL Inc
$ 1.45
(-29.65%)
781.69k
PRTGPortage Biotech Inc
$ 0.245
(-27.94%)
70.68k
JAGXJaguar Health Inc
$ 0.1814
(52.69%)
430.19M
WISAWiSA Technologies Inc
$ 3.775
(115.71%)
70.74M
SQQQProShares UltraPro Short QQQ
$ 11.44
(0.00%)
66.26M
NKLANikola Corporation
$ 0.6823
(4.39%)
50.66M
TSLATesla Inc
$ 156.8801
(-2.85%)
49.44M

Your Recent History

Delayed Upgrade Clock